Advertisement

Topics

FDA Accepts Otsuka's Resubmission to Support a Regulatory Review of Tolvaptan in the Treatment of...

19:00 EST 8 Nov 2017 | BioSpace

The FDA considers the resubmission to be filed as of October 24, 2017, with a PDUFA action date of April 24, 2018.

Original Article: FDA Accepts Otsuka's Resubmission to Support a Regulatory Review of Tolvaptan in the Treatment of...

NEXT ARTICLE

More From BioPortfolio on "FDA Accepts Otsuka's Resubmission to Support a Regulatory Review of Tolvaptan in the Treatment of..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...